Key result
Targeting vascular aging mechanisms via imaging biomarkers offers a path to novel cardiovascular therapies.
Why the study?
Molecular and signal transduction mechanisms are increasingly central to understanding vascular disease pathology, and the interplay between basic science and clinical experience in vascular aging often yields counterintuitive findings.
This narrative review summarizes the cellular and molecular mechanisms of vascular aging—including oxidative stress, endothelial dysfunction, and inflammation—alongside key imaging vascular biomarkers to inform novel treatment strategies for age-related cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
May inform personalized CV therapies via vascular imaging biomarkers; leaves open validation in prospective outcome trials.
The vasculature is a highly complex organ system capable of sensing alterations in its surroundings, promptly transducing signals to vascular and surrounding tissue cells, and synthesizing local mediators that induce both acute and chronic functional and structural adaptive responses. Vascular aging (VA) results from the combined effects of congenital and acquired risk factors and their interactions, and is a natural and inevitable contributor to age-related cardiovascular (CV) diseases. Atherosclerosis, arterial hypertension, and other CV diseases progressively lead to vascular dysfunction through multiple consecutive and interconnected pathological processes, including oxidative stress with reactive oxygen species (ROS) formation, endothelial dysfunction, mitochondrial dysfunction, systemic inflammation, and autophagy. As molecular and signal transduction mechanisms become increasingly central to understanding vascular disease pathology—and as the interplay between basic science and clinical experience often yields counterintuitive findings—this narrative review summarizes the pathological changes of VA, tracing the process from the cellular level to clinically manifest vascular disorders, and describes in detail the most important imaging markers of the aging process. Furthermore, the review examines the essential mechanisms of vascular aging–related dysfunction from a fresh mechanistic perspective, aiming to inform and optimize the development of novel treatment strategies for patients with age-related CV diseases.
No takes yet. Share an insight, caveat, or question.
Dušan Petrović (2026) conducted a review in Vascular aging and age-related cardiovascular diseases. Imaging vascular biomarkers was evaluated. Vascular aging involves interconnected mechanisms like oxidative stress, inflammation, and endothelial dysfunction that can be tracked via imaging biomarkers to inform novel cardiovascular treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: